Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STRYKER NEUROVASCULAR CORK TARGET 360 NANO 1.5MM X 3CM; DEVICE, NEUROVASCULAR EMBOLIZATION
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STRYKER NEUROVASCULAR CORK TARGET 360 NANO 1.5MM X 3CM; DEVICE, NEUROVASCULAR EMBOLIZATION Back to Search Results
Model Number M0035421530
Device Problem Premature Activation (1484)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/05/2020
Event Type  malfunction  
Manufacturer Narrative
Device not received for evaluation.
 
Event Description
It was reported that during a coil embolization procedure, the coil (subject device) prematurely detached inside the microcatheter.Both the microcatheter and the coil were removed and replaced and the procedure was completed successfully.There were no clinical consequences to the patient.
 
Event Description
It was reported that during a coil embolization procedure, the coil (subject device) prematurely detached inside the microcatheter.Both the microcatheter and the coil were removed and replaced and the procedure was completed successfully.There were no clinical consequences to the patient.
 
Manufacturer Narrative
Update: h4 manufacturing date ¿ added h3 device evaluated by mfg ¿updated h3 summary attached - updated d4 expiration date - added d10 product available to stryker ¿ updated d10 returned to manufacturer on ¿updated the returned product was confirmed to be the product reported in the complaint.The lot number was confirmed with the packaging returned with the device.During visual inspection, it was noted the main coil was stretched and found manually detached.The coil delivery wire was not returned for analysis.Functional inspection was unable to be carried out as the main coil was detached, however the reported events confirmed during analysis are consistent with the event.Due to the automated mes system there are controls in the manufacturing process to ensure the product met specifications upon release.The edhr (electronic device history record) for each lot is created and maintained in mes (manufacturing execution system).Automated controls within the mes system ensure that all product is manufactured in accordance to the dmr (device master record).The reported event is covered in the device directions for use (dfu).As well, the risk of the reported event is documented in the risk documentation and there are current controls to mitigate the risk of the as reported event.The event is anticipated and contained in the rmf.The device was returned for analysis and the reported defect was not confirmed however, the analysis results are consistent with the event.The device failed to meet specifications when received for complaint investigation based on the analyzed anomalies noted to the device.Additional information provided by the customer indicated that intermittent flush was maintained.As per the dfu, ¿in order to achieve optimal performance of the target detachable coil system and to reduce the risk of thromboembolic complications, it is critical that a continuous infusion of appropriate flush solution be maintained between a) the femoral sheath and guiding catheter, b) the 2-tip microcatheter and guiding catheters, and c) the 2-tip microcatheter and stryker neurovascular guidewire and delivery wire.Continuous flush also reduces the potential for thrombus formation on, and crystallization of infusate around, the detachment zone of the target detachable coil.¿ it is probable that insufficient flush caused the reported defect.Based on the investigation results and available information an assignable cause of user error will be assigned to as reported events.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TARGET 360 NANO 1.5MM X 3CM
Type of Device
DEVICE, NEUROVASCULAR EMBOLIZATION
Manufacturer (Section D)
STRYKER NEUROVASCULAR CORK
ida industrial estate
model farm road
cork NA
IE  NA
MDR Report Key9897537
MDR Text Key186205037
Report Number3008881809-2020-00079
Device Sequence Number1
Product Code HCG
UDI-Device Identifier04546540697943
UDI-Public04546540697943
Combination Product (y/n)N
PMA/PMN Number
K153658
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 06/04/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2020
Device Model NumberM0035421530
Device Catalogue NumberM0035421530
Device Lot Number20089760
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/24/2020
Initial Date Manufacturer Received 03/05/2020
Initial Date FDA Received03/30/2020
Supplement Dates Manufacturer Received05/26/2020
Supplement Dates FDA Received06/04/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
LEONISMOVA MICROCATHETER (SUMITOMO)
-
-